A phase I/II study (TaxXel) on the treatment with docetaxel in combination with capecitabin in patients with metastatic esophageal cancer or cancer in the cardia region.
Signe Friesland
No relevant relationships to disclose
Gun Wickart-Johansson
No relevant relationships to disclose
Lianna Kadar
No relevant relationships to disclose
Charlotte Bratthall
No relevant relationships to disclose
Henry Letocha
No relevant relationships to disclose
Lars Franzen
No relevant relationships to disclose
Anne-Birgitte Jacobsen
No relevant relationships to disclose
Petra Weber Hauge
No relevant relationships to disclose
Gunnar Wagenius
No relevant relationships to disclose
Ingunn Hatlevoll
No relevant relationships to disclose
Nils Glenjen
No relevant relationships to disclose